Breast cancer stem cells: treatment resistance and therapeutic opportunities (Q37839530)

24 August 2017

1 reference

title

Breast cancer stem cells: treatment resistance and therapeutic opportunities (English)

1 reference

24 August 2017

neoplastic stem cells

1 reference

1 reference

Georgia Chenevix-Trench

4

Georgia Chenevix-Trench

0 references

Michael P. Brown

Michael P Brown

7

0 references

Fares Al-Ejeh

Fares Al-Ejeh

1

0 references

Sunil R Lakhani

Sunil R Lakhani

6

0 references

author name string

Chanel E Smart

2

1 reference

24 August 2017

Brian J Morrison

3

1 reference

24 August 2017

J Alejandro López

5

1 reference

24 August 2017

Kum Kum Khanna

8

1 reference

24 August 2017

language of work or name

English

0 references

publication date

10 February 2011

1 reference

24 August 2017

1 reference

24 August 2017

32

1 reference

24 August 2017

5

1 reference

24 August 2017

650-658

1 reference

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

24 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Multidisciplinary approach of early breast cancer: the biology applied to radiation oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Tumour stem cells: the biological concept and its application in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Insights into the cell of origin in breast cancer and breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Heterogeneity in cancer: cancer stem cells versus clonal evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Stem cells in the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Mammary stem cells, self-renewal pathways, and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Generation of a functional mammary gland from a single stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Evidence for a stem cell hierarchy in the adult human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Detection and analysis of mammary gland stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Breast cancer stem cells and intrinsic subtypes: controversies rage on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Transcriptome analysis of the normal human mammary cell commitment and differentiation process

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

A tumorigenic subpopulation with stem cell properties in melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Phenotypic characterization of human colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Beyond tumorigenesis: cancer stem cells in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Molecular definition of breast tumor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Cell type-specific DNA methylation patterns in the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

A functional Notch-survivin gene signature in basal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Breast tumor heterogeneity: cancer stem cells or clonal evolution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Cancer cell of origin: spotlight on luminal progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Is tumor growth sustained by rare cancer stem cells or dominant clones?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Identification of tumor-initiating cells in a p53-null mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Cancer stem cells versus phenotype-switching in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

The pathology of EMT in mouse mammary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Cancer stem cells: back to Darwin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Association of reactive oxygen species levels and radioresistance in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

In vivo imaging, tracking, and targeting of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Exploring the role of cancer stem cells in radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Treatment resistance in stem cells and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

The role of DNA damage repair in aging of adult stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

The bright and the dark sides of DNA repair in stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

The cancer stem cell microenvironment and anti-cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

DNA damage repair and response proteins as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

DNA double-strand breaks: signaling, repair and the cancer connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Senescence evasion by MCF-7 human breast tumor-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Radiation resistance in breast cancer: are CD44+/CD24-/proteosome low/PKH26+ cells to blame?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Cancer stem cells in breast cancer and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Targeting breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Breast cancer stem cells: implications for therapy of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

The difficulty of targeting cancer stem cell niches

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

The Hedgehog signalling pathway as a therapeutic target in early breast cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Hedgehog signalling in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Targeting Hedgehog--a cancer stem cell pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Targeting Notch to target cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Targeting Wnt signaling: can we safely eradicate cancer stem cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Targeted therapy for cancer stem cells: the patched pathway and ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Cancer stem cells: how can we target them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Selective targeting of radiation-resistant tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Cross-talk between Notch and EGFR signaling in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

EN2 is a candidate oncogene in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Hsp90 inhibitors as promising agents for radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Targeting the perpetrator: breast cancer stem cell therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

BH3 peptidomimetics potently activate apoptosis and demonstrate single agent efficacy in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Survivin: a promising tumor biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

IAP-targeted therapies for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Identification of selective inhibitors of cancer stem cells by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Inhibition of poly(ADP-ribose) polymerase in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Targeting poly(ADP-ribose) polymerase: a two-armed strategy for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Targeted therapy for cancer using PARP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Chk1 inhibitors for novel cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Small-molecule modulators of the Sonic Hedgehog signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Therapeutic antibody targeting of individual Notch receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Cancer stem cell targeting using the alpha-particle emitter, 213Bi: mathematical modeling and feasibility analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Multifunctional core-shell magnetic cisplatin nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Immunotargeting of Functional Nanoparticles for MRI detection of Apoptotic Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

Stem Cells and Cancer: Two Faces of Eve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR028

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGR028

1 reference

24 August 2017

1 reference